Please login to the form below

Not currently logged in
Email:
Password:

Positive opinion for Allergan's NDO treatment

A positive opinion is given from the Irish Medicines Board for BOTOX treatment for neurogenic detrusor overactivity (NDO)

Allergan's BOTOX has received a positive opinion from the Irish Medicines Board, for the use of BOTOX for the management of urinary incontinence in adults with neurogenic detrusor overactivity (NDO).

NDO results from neurogenic bladder, due to stable sub-cervical spinal cord injury (SCI) or multiple sclerosis (MS). NDO results in involuntary contractions of the detrusor muscle within the bladder during its filling stage. This over activity often leads to urinary incontinence.

It has been shown that targeted injections of BOTOX into the bladder muscle can reduce the involuntary contractions and increase bladder capacity, therefore reducing the number of urinary leaks.

Gaining this opinion is considered to be an important step towards securing national licences in the 14 European countries involved in the Mutual Recognition Procedure.

9th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics